Wael Saeb
7Patents
4h-index
20Co-inventors
53Inventor score
Filing activity: Feb 26, 2002 → Jan 27, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7335779B2 | Modulation of pathogenicity | Emerging Cross-Sectional Technologies | 33 | Expired |
| US7338969B2 | Modulation of pathogenicity | Emerging Cross-Sectional Technologies | 29 | Expired |
| US7423057B2 | Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents | Chemistry; Metallurgy | 7 | Expired |
| US7176241B2 | Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents | Chemistry; Metallurgy | 5 | Expired |
| US6949567B2 | Compounds for the treatment of protozoal diseases | Chemistry; Metallurgy | 4 | Expired |
| US8592456B2 | IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation | Human Necessities | 2 | Active |
| US8354436B2 | IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation | Chemistry; Metallurgy | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.